Literature DB >> 26560258

Management of gallstones and its related complications.

P Portincasa1, A Di Ciaula2, O de Bari1,3, G Garruti4, V O Palmieri1, D Q-H Wang3.   

Abstract

The majority of gallstone patients remain asymptomatic; however, interest toward the gallstone disease is continuing because of the high worldwide prevalence and management costs and the development of gallstone symptoms and complications. For cholesterol gallstone disease, moreover, a strong link exists between this disease and highly prevalent metabolic disorders such as obesity, dyslipidemia, type 2 diabetes, hyperinsulinemia, hypertriglyceridemia and the metabolic syndrome. Information on the natural history as well as the diagnostic, surgical (mainly laparoscopic cholecystectomy) and medical tools available to facilitate adequate management of cholelithiasis and its complications are, therefore, crucial to prevent the negative outcomes of gallstone disease. Moreover, some risk factors for gallstone disease are modifiable and some preventive strategies have become necessary to reduce the onset and the severity of complications.

Entities:  

Keywords:  cholecystectomy; cholecystitis; choledocholithiasis; complications; gallbladder cancer; gallstones; oral litholysis; prevention; risk factors

Mesh:

Year:  2015        PMID: 26560258     DOI: 10.1586/17474124.2016.1109445

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  22 in total

Review 1.  Cholecystectomy and risk of metabolic syndrome.

Authors:  Agostino Di Ciaula; Gabriella Garruti; David Q-H Wang; Piero Portincasa
Journal:  Eur J Intern Med       Date:  2018-04-26       Impact factor: 4.487

Review 2.  An update on the pathogenesis of cholesterol gallstone disease.

Authors:  Agostino Di Ciaula; David Q-H Wang; Piero Portincasa
Journal:  Curr Opin Gastroenterol       Date:  2018-03       Impact factor: 3.287

3.  Gallbladder Polypoid-Lesions: What Are They and How Should They be Treated? A Single-Center Experience Based on 1446 Cholecystectomy Patients.

Authors:  Anan Xu; Yu Zhang; Hai Hu; Gang Zhao; Jinli Cai; Anhua Huang
Journal:  J Gastrointest Surg       Date:  2017-07-10       Impact factor: 3.452

Review 4.  Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.

Authors:  Helen H Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  Prevalence of Gallstones in Ulcerative Colitis and Crohn's Disease: A Systematic Review and Meta-Analysis.

Authors:  Mirza M A Baig; Shayan A Irfan; Anusha Sumbal; Ramish Sumbal; Sanjay Kumar; Junaid Ahmad; Nikhila Gandrakota; Laila Tul Qadar; Maida S Chaudhry; Azka Feroz; Muhammad Sheharyar Warraich
Journal:  Cureus       Date:  2022-06-20

6.  Effect of Endoscopic Retrograde Cholangiopancreatography Lithotomy Combined with Laparoscopic Cholecystectomy on Pain and Prognosis of Patients with Gallstones and Extrahepatic Bile Duct Stones.

Authors:  Hui Zhao; Jian Zhang
Journal:  Comput Intell Neurosci       Date:  2022-06-27

7.  Comparative Study of the Results of Operations in Patients with Tumor and Non-Tumor Obstructive Jaundice Who Received and Did Not Receive Antioxidant Therapy for the Correction of Endotoxemia, Glycolysis, and Oxidative Stress.

Authors:  Victor Stupin; Igor Abramov; Teymur Gahramanov; Alexey Kovalenko; Natalia Manturova; Petr Litvitskiy; Zalim Balkizov; Ekaterina Silina
Journal:  Antioxidants (Basel)       Date:  2022-06-20

8.  Gastrointestinal defects in gallstone and cholecystectomized patients.

Authors:  Agostino Di Ciaula; Emilio Molina-Molina; Leonilde Bonfrate; David Q-H Wang; Dan L Dumitrascu; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2019-01-29       Impact factor: 4.686

9.  Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment.

Authors:  N Prencipe; C Bona; D Cuboni; M Parasiliti-Caprino; A M Berton; L M Fenoglio; V Gasco; E Ghigo; S Grottoli
Journal:  Pituitary       Date:  2020-11-09       Impact factor: 4.107

10.  Body Mass Index Can Increase the Risk of Gallbladder Cancer: A Meta-Analysis of 14 Cohort Studies.

Authors:  Hao Liu; Yong Zhang; Min Ai; Jun Wang; Bo Jin; Zhaowei Teng; Yansheng Wang; Li Li
Journal:  Med Sci Monit Basic Res       Date:  2016-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.